Dedicated to solving the problem of antibiotic and antiviral resistance.

Pipeline

Anti-infectives Portfolio

At Venatorx Pharmaceuticals, we are pursuing novel chemical approaches to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections. All of our investigational molecules were discovered internally.

At Venatorx Pharmaceuticals, we are pursuing novel chemical approaches to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections. All of our investigational molecules were discovered internally.

Expanded Access

Venatorx Pharmaceuticals (the “Company”) is focused on conducting clinical studies and obtaining regulatory approval of investigational medicines in support of its mission to develop safe and effective treatments for infectious diseases. The best way for patients to get access to investigational medicines is by taking part in clinical trials. Please search ClinicalTrials.gov for publicly available information related to Venatorx’s ongoing clinical trials. READ MORE